Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Symphogen licenses Sym-004 to Merck KGaA

Sep. 10, 2012

Astex Pharmaceuticals enters epigenetic drug discovery collaboration

Sep. 7, 2012

Medivir acquires preclinical antiviral programs from Novadex

Sep. 5, 2012

Myrexis returns compounds to EpiCept

Sep. 5, 2012

BioLineRx and Biokine Therapeutics enter licensing agreement for hematological cancers

Sep. 5, 2012

Agios and UPenn establish new collaboration

Sep. 4, 2012

BioFocus and Ono Pharmaceutical to collaborate on CNS drugs

Sep. 4, 2012

VLST licenses CP-870893 from Pfizer

Sep. 3, 2012

NeuroSearch transfers Janssen research collaboration agreement to Aniona

Sep. 3, 2012

Genmab and Janssen Biotech form worldwide agreement

Aug. 31, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...